IPOs

Inhibrx Files for $75 Million IPO
Inhibrx
IPOs
Flag link:
Adaptive Biotechnologies Files for $230 Million IPO
Adaptive Biotechnologies Files for $230 Million IPO
CP Wire
Adaptive Biotechnologies
IPOs
Genentech
Flag link:
Adaptive Biotechnologies Files for $230 Million IPO
Adaptive Biotechnologies
Genentech
IPOs
Flag link:
Genmab files for $500M IPO to fund multi-front cancer R&D push
Genmab files for $500M IPO to fund multi-front cancer R&D push
Fierce Biotech
Genmab
IPOs
antibody-drug conjugate
cervical cancer
Flag link:
New IPO filings include BridgeBio, Dermavant, Prevail, Atreca, Akero
New IPO filings include BridgeBio, Dermavant, Prevail, Atreca, Akero
BioCentury
IPOs
BridgeBio
Dermavant
Prevail Therapeutics
Atreca
Akero Therapeutics
Flag link:
Ideaya wraps $50M IPO to fuel clinical drive on synthetic lethality
Ideaya wraps $50M IPO to fuel clinical drive on synthetic lethality
Endpoints
Ideaya
IPOs
cancer
Flag link:
Stoke Therapeutics Files for $86 Million IPO
Stoke Therapeutics Files for $86 Million IPO
CP Wire
Stoke Therapeutics
Dravet syndrome
IPOs
Flag link:
Bicycle raises $61M in downsized IPO, joining fellow biotechs on Nasdaq who have hauled in $1.6B collectively
Bicycle raises $61M in downsized IPO, joining fellow biotechs on Nasdaq who have hauled in $1.6B collectively
Endpoints
Bicycle Therapeutics
IPOs
Flag link:
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs
Yahoo/Benzinga
Incyte
Novartis
Athersys
ResTORbio
Bellerophon Therapeutics
Eli Lilly
CymaBay
Bicycle Therapeutics
Peloton Therapeutics
Ideaya
IPOs
Flag link:
Bicycle Therapeutics Updates Filing for $80 Million IPO
Bicycle Therapeutics Updates Filing for $80 Million IPO
CP Wire
Bicycle Therapeutics
IPOs
drug development
Flag link:
Bicycle Therapeutics Updates Filing for $80 Million IPO
Bicycle Therapeutics
IPOs
Flag link:
Why dwarfism start-up Therachon picked Pfizer takeout over IPO
Why dwarfism start-up Therachon picked Pfizer takeout over IPO
BioCentury
Pfizer
Therachon
IPOs
Flag link:
Two Days, Five Biotech IPOs, and $359M Raised for Clinical Trials
Two Days, Five Biotech IPOs, and $359M Raised for Clinical Trials
Xconomy
IPOs
clinical trials
Axcella Health
Cortexzyme
Milestone Pharmaceuticals
NextCure
Trevi Therapeutics
Flag link:
Codiak Biosciences Lines up for $86 Million IPO
Codiak Biosciences Lines up for $86 Million IPO
BioSpace
Codiak Biosciences
IPOs
exosomes
Flag link:
Can 'synthetic lethality' and deep experience propel this cancer-fighting biotech's $70M IPO?
Can 'synthetic lethality' and deep experience propel this cancer-fighting biotech's $70M IPO?
Bizjournals
Ideaya
Novartis
IPOs
cancer
Flag link:
Bicycle files for $86M IPO to fund trials of novel drug conjugates
Bicycle files for $86M IPO to fund trials of novel drug conjugates
Fierce Biotech
Bicycle Therapeutics
IPOs
BT1718
Flag link:
Immunotherapy Focused NextCure Updates Its Filing for $93 Million IPO
Immunotherapy Focused NextCure Updates Its Filing for $93 Million IPO
CP Wire
NextCure
IPOs
immuno-oncology
Flag link:
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs
Yahoo/Benzinga
Regeneron
Sanofi
Praluent
FDA
Heron Therapeutics
HTX-011
Nabiva
Orchard Therapeutics
Akari Therapeutics
Aldeyra Therapeutics
BioTime
Audentes Therapeutics
Adaptimmune
GW Pharma
Ionis
Biogen
Ovid Therapeutics
TransMedics
IPOs
Trevi Therapeutics
Flag link:
Schizophrenia therapy developer Karuna seeking IPO
Schizophrenia therapy developer Karuna seeking IPO
BioCentury
IPOs
Karuna
antipsychotics
schizophrenia
Flag link:
Applied Therapeutics Updates IPO Filing
Applied Therapeutics Updates IPO Filing
CP Wire
Applied Therapeutics
IPOs
Flag link:

Pages